John F. Neylan, Chief Medical Officer at KERYX BIOPHARMACEUTICALS INC (KERX), sold 1,311 shares at $4.67 ($6K) on 2018-04-30, disclosed to the SEC on 2018-05-01.
Open-market sale of $6k KERX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANGN | SELL | 2021-10-20 | $3K | — | Filing → |
| ANGN | SELL | 2021-09-21 | $4K | — | Filing → |
| ANGN | SELL | 2021-08-19 | $3K | — | Filing → |